Cytk earnings
WebApr 6, 2024 · CYTK Cytokinetics, Incorporated Stock Price & Overview $35.39 -0.79 ( -2.18%) 1:21 PM 03/22/23 NASDAQ $USD Realtime Summary Ratings Financials Earnings Dividends Valuation Growth... WebMar 1, 2024 · Earnings of $3.61 per share missed Zacks Consensus Estimate and our model estimates of $4.66 and $4.48, respectively. Earnings declined year over year due to lower revenues and higher operating ...
Cytk earnings
Did you know?
WebMar 1, 2024 · Earnings from Moderna (BIIB) and updates from Regeneron (REGN) are the key highlights from the biotech sector during the past week. Biotech Stock Roundup: MRNA Q4 Earnings, REGN's Updates, CYTK ... WebCytokinetics (CYTK) will release its next earnings report on May 11, 2024. In the last quarter Cytokinetics reported -$1.206 EPS in relation to -$1.45 expected by the market.
WebApr 9, 2024 · Cytokinetics (NASDAQ:CYTK – Get Rating) last issued its quarterly earnings results on Wednesday, March 1st. The biopharmaceutical company reported ($1.45) EPS for the quarter, missing analysts ... WebApr 11, 2024 · Cytokinetics (NASDAQ:CYTK) has a market capitalization of $3.48 billion and generates $94.59 million in revenue each year. The biopharmaceutical company earns $ …
WebApr 13, 2024 · Analyst price target for CYTK is US$60.06, which is 58% above our fair value estimate. ... Debt is well covered by earnings. Weakness. Shareholders have been diluted in the past year. WebCYTK Analyst Estimates Stock Screener Earnings Calendar Sectors Nasdaq CYTK U.S.: Nasdaq Cytokinetics Inc. Watch list Create CYTK Alert Open Last Updated: Sep 16, …
WebMar 2, 2024 · Press Release. EPS of -$1.45 misses by $0.24 Revenue of $1.96M (-96.48% Y/Y) misses by $4.51M. Cytokinetics, Incorporated ( NASDAQ: CYTK) Q4 2024 …
WebApr 13, 2024 · Analyst price target for CYTK is US$60.06, which is 58% above our fair value estimate. ... Debt is well covered by earnings. Weakness. Shareholders have been … great lakes oncology buffalo nyWebApr 12, 2024 · Cytokinetics (NASDAQ:CYTK – Get Rating) last posted its earnings results on Wednesday, March 1st. The biopharmaceutical company reported ($1.45) earnings per share (EPS) for the quarter, missing ... floaty trouser suits for weddings plus sizeWebThe Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ... great lakes online academyWebApr 9, 2024 · The company has a market capitalization of $3.48 billion, a price-to-earnings ratio of -8.57 and a beta of 0.80. Cytokinetics, Incorporated has a 12-month low of $32.96 and a 12-month high of $55.80. floaty t shirtsWebApr 10, 2024 · Key profitability statistics from the latest earnings report; CYTK income statement (TTM) Revenue: US$94.59m: Cost of Revenue: US$240.81m: Gross Profit-US$146.22m: Other Expenses: US$242.73m: Earnings-US$388.95m: Last Reported Earnings. Dec 31, 2024. Next Earnings Date. n/a. Earnings per share (EPS)-4.07: … great lakes oncology michiganWebApr 10, 2024 · In the past 30 days, estimates for Novo Nordisk’s 2024 earnings per share have risen from $4.20 to $4.43 and estimates for 2024 have gone up by 29 cents to $5.19. great lakes oncology buffaloWebApr 6, 2024 · Cytokinetics, Incorporated (CYTK) latest earnings report: revenue, EPS, surprise, history, news and analysis. floaty trouser suits for wedding guest